Home

Recent Articles from Investor Brand Network

Investor Brand Network (IBN) is a dynamic financial news and publishing company headquartered in Los Angeles, California, dedicated to enhancing corporate communications for over 500 public and private client partners across various industries. Established over 19 years ago, IBN has cultivated a portfolio of more than 70 specialized brands, amassing a collective audience of millions of social media followers, and leverages this reach to provide innovative solutions such as InvestorWire for wire-grade dissemination, article syndication to over 5,000 news outlets, and enhanced press release services.

420 with CNW — LA Council Approves Higher License Fees for Marijuana Businesses
Cannabis operators in Los Angeles will face steeper renewal fees after the City Council unanimously approved a hike recently, putting added pressure on an industry already dealing with thin margins and increasing competition.
Via Investor Brand Network · August 11, 2025
TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Drivers Deliver Strong Results at Grand Prix of Portland
SEGG Media (NASDAQ: SEGG, LTRYW) saw its Lottery.com and Sports.com brands prominently displayed across the NTT INDYCAR and INDY NXT by Firestone paddocks this weekend as SEGG-backed drivers posted solid performances in the final road course race of the 2025 season at the BitNile.com Grand Prix of Portland. Callum Ilott (PREMA Racing) climbed 18 positions from P24 to finish P6, matching his career-best result and securing PREMA’s fourth straight top-10. Louis Foster (Rahal Letterman Lanigan Racing) recovered from an early spin to finish P13, maintaining his lead in the INDYCAR Rookie of the Year standings. In his Portland debut, Seb Murray (Andretti Cape) was caught in a Lap 1 incident but finished P16, gaining valuable race mileage ahead of the season’s final two oval rounds. SEGG branding was highly visible throughout the weekend, with Lottery.com and Sports.com logos featured prominently on cars, helmets, race suits, and equipment.
Via Investor Brand Network · August 11, 2025
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Mining Operation in Quebec Shows Open Potential for Revenues
Gold and silver recovery company ESGold (CSE: ESAU) (OTCQB: ESAUF) is preparing the site before setting in motion its near-term plan for revenue generation at the historic Montauban Mine project in eastern Canada, where the company owns 265 mining claims covering 13,116 hectares (about 32,410 acres).
Via Investor Brand Network · August 11, 2025
TechMediaBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Secures U.S. Patent for Gesture and Voice-Controlled Neural Interface
Wearable Devices (NASDAQ: WLDS, WLDSW), a technology growth company specializing in AI-powered touchless sensing wearables, announced that the United States Patent and Trademark Office has granted its patent titled “Gesture and Voice-Controlled Interface Device.” The patent covers proprietary neural interface technology enabling gesture-based control and real-world physical measurements from the wrist, including object weight estimation, torque and force measurement, and integration with voice commands, XR embodiment, and brain-computer interface innovations. The protected technology supports applications in XR immersion, industrial efficiency, logistics accuracy, and assistive solutions for individuals with severe disabilities. The grant advances the company’s IP strategy and reinforces its position in developing next-generation wearable bio-potential sensors.
Via Investor Brand Network · August 11, 2025
Meta Announces Updated Scam Detection Alerts for WhatsApp
Meta has introduced new safety features to protect WhatsApp users from online scams. As scams continue to grow across messaging platforms, this update aims to make it harder for scammers to reach people and trick them into giving away personal information.
Via Investor Brand Network · August 11, 2025
How to Rebuild Trust in the US Healthcare System
A recent survey undertaken by Gallup in 2025 found that since 2021, there has been a 14% drop in the level of the public’s trust in the physicians who take care of them. This decline was the steepest among the declines registered by all the professions focused on.
Via Investor Brand Network · August 7, 2025
Study Reveals Potential Way to Treat Pediatric Gliomas
A joint study between the Broad Institute and the Dana-Farber Cancer Institute has discovered a new and potentially effective way to treat pediatric gliomas. The research revealed that a percentage of children diagnosed with gliomas, an incredibly common type of pediatric brain cancer, may respond to certain inhibitors that have already been approved by the U.S. Food and Drug Administration.
Via Investor Brand Network · August 11, 2025
InvestorNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Hits $100 Million in Transaction Volume for Licensed Coin-In/Coin-Out Services
Solowin (NASDAQ: SWIN), a financial services firm bridging traditional and digital assets, announced that its wholly owned subsidiary Solomon JFZ (Asia) Holdings Limited (“Solomon”) has processed $100 million in total transaction volume since launching licensed coin-in and coin-out services in Hong Kong. The milestone follows Solomon’s recent licensing from the Hong Kong Securities and Futures Commission, enabling regulated fiat-to-digital asset connectivity under the city’s stringent compliance standards. Solomon’s platform meets rigorous asset custody, AML/KYC, and market integrity requirements while holding the majority of client assets in cold storage. Positioned to leverage its first-mover advantage, Solowin plans to deepen partnerships with global stablecoin issuers, explore institutional staking products, and expand into real-world asset tokenization and institutional-grade DeFi solutions.
Via Investor Brand Network · August 11, 2025
InvestorNewsBreaks – Alliance Global Partners Maintains Buy Rating, Increases Price Target as Soligenix Inc. (NASDAQ: SNGX) Advances Proprietary Clinical Programs
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted last week in a report from Alliance Global Partners (“AGP”), which maintained its Buy rating for Soligenix and raised SNGX’s price target to $10 per share. According to the report, the increase was based on the increasing valuation of HyBryte(TM) for the treatment of early-stage cutaneous T cell lymphoma (“CTCL”) and new estimated valuation for Soligenix’s SGX945, a treatment for Behçet’s disease.
Via Investor Brand Network · August 11, 2025
BioMedNewsBreaks — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Signs CDMO Agreement for Oral Lucid-MS in Phase 2 MS Trial
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that its subsidiary, Huge Biopharma Australia Pty Ltd., has signed an agreement with a leading contract development and manufacturing organization to produce an oral formulation of Lucid-MS for the company’s upcoming Phase 2 clinical trial. The trial will evaluate Lucid-MS as a potential treatment to help restore mobility in people with multiple sclerosis (MS), building on a decade of preclinical studies in which the therapy enabled animals to regain their ability to walk. Lucid-MS is a patented, first-in-class, non-immunomodulatory neuroprotective compound that has demonstrated the ability to prevent demyelination, a hallmark of MS and other neurodegenerative diseases. The agreement marks a key step toward filing an Investigational New Drug application with the FDA for Lucid-21-302 in MS.
Via Investor Brand Network · August 11, 2025
InvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Highlights Q2 2025 Progress and Prepares for Phase IIa Concussion Trial
Oragenics (NYSE American: OGEN), a biotechnology company developing brain-targeted therapeutics via proprietary intranasal delivery technology, reported strategic and financial milestones for Q2 2025 as it advances its lead candidate, ONP-002, toward becoming the first FDA-approved pharmacological treatment for concussion. The company secured Human Research Ethics Committee approval in Australia, appointed Southern Star Research as CRO, and finalized a U.S.-based cGMP manufacturing agreement with Sterling Pharma Solutions. Phase IIa trials are expected to launch in Q3 2025. Oragenics’ intranasal delivery platform enables rapid, targeted drug delivery to the brain, bypassing systemic circulation and reducing side effects, with potential applications beyond concussion to acute neurological emergencies and chronic neurodegenerative diseases. The global nasal drug delivery market is projected to exceed $40 billion by 2030.
Via Investor Brand Network · August 11, 2025
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Steps Aside Temporarily to Run for Irish Presidency
Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will step aside for three months to pursue candidacy in the Irish Presidential election, with nomination hearings and voting taking place in September and October. Co-Founder and Chairman Serguei Melnik, a corporate strategy expert with over 20 years in capital markets, will assume CEO duties during this period, guiding the company toward its 2026 NDA filing target. Sheridan emphasized confidence in the leadership team, noting continued progress on AVERSA Fentanyl, which the FDA recently granted a meeting request for. AVERSA Fentanyl is positioned to be the first abuse-deterrent opioid patch, designed to deter misuse and accidental exposure, with potential peak U.S. sales estimated at $80 million to $200 million. The technology is protected by patents in 46 countries, with plans to expand availability to major global medical markets.
Via Investor Brand Network · August 11, 2025
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Q2 2025 Results and Business Highlights
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted therapies to deliver genetic medicines to metastatic disease sites, reported a Q2 2025 net loss of $5.7 million, or $1.99 per share, compared to a net loss of $7.4 million, or $16.75 per share, in Q2 2024. R&D expenses were $2.6 million versus $2.2 million last year, while G&A expenses were $3.1 million compared to $3.6 million. Calidi ended the quarter with $5.3 million in cash and $0.1 million in restricted cash. Recent highlights include new preclinical data on CLD-401 from the proprietary RedTail platform, showing enhanced efficacy through systemic delivery of an IL15 superagonist and immune-evasion via engineered CD55 expression; $4.6 million raised in a warrant inducement offering, bringing 2025 gross proceeds to $15.7 million; and FDA Fast Track Designation for CLD-201 in soft tissue sarcoma, with an open IND for a Phase 1 trial.
Via Investor Brand Network · August 11, 2025
BioMedNewsBreaks — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Fast Track Designation for NRX-100 in Treating Suicidal Ideation in Depression
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to NRX-100 for treating suicidal ideation in patients with depression, including bipolar depression—a 10-fold expansion from its prior 2017 designation for use with NRX-101 in suicidal bipolar depression. The FDA’s determination, based on preliminary data, also supports potential eligibility for the Commissioner’s National Priority Voucher Program and the Accelerated Approval Program. Controlled trials licensed by NRx showed NRX-100 (IV ketamine) reduced suicidal ideation significantly, with one Columbia University study reporting a 55% response rate versus 30% for active comparator (P<.02) and a French government-sponsored trial showing 63% remission in three days versus 31% with placebo (P<.001). NRx plans to post an expanded access policy within two weeks and meet with FDA leadership to finalize data for submission under the Accelerated Approval/CNPV pathway.
Via Investor Brand Network · August 11, 2025
Saxo Bank Foresees Further Bullish Movement for Gold This Year
After the price of gold climbed to historic levels during the first half of this year and has since been trading sideways for several weeks in a row, many investors could be wondering whether the bull run has now completed its course and they should take their profits before a trend reversal occurs. Saxo Bank thinks the horizontal price movement is just a pause and there is plenty of room for additional upward movement .
Via Investor Brand Network · August 11, 2025
InvestorNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Drivers Set for Grand Prix of Portland
SEGG Media (NASDAQ: SEGG, LTRYW) announced that sponsored drivers Callum Ilott, Louis Foster, and Seb Murray were set to compete this past weekend in the 2025 NTT INDYCAR and INDY NXT by Firestone Grand Prix of Portland, the final road course before the season-ending oval double-header. The 12-turn, 1.964-mile Portland International Raceway is known for its multiple overtaking zones and unpredictable action through Turn 1’s ‘Festival Curves.’ Ilott, racing for PREMA and carrying Lottery.com branding, returned to the venue where he debuted in IndyCar, aiming to build on consistent performances. Foster, with Sports.com logos, entered the event leading the Rookie of the Year standings and looking to extend his strong road course record. Murray, representing Andretti Cape and backed by Lottery.com and Sports.com, was making his Portland debut after a career-best P5 at Monterey, seeking to carry that momentum into the season’s closing stretch.
Via Investor Brand Network · August 11, 2025
420 with CNW — Proposed Pennsylvania Bill Would Make Employers Cover Medical Cannabis Under Workers’ Compensation
A new bill focusing on medical marijuana and workers’ compensation has been introduced in the Pennsylvania legislature as debate over legalizing recreational cannabis gains momentum. The bill, introduced by Representative David Delloso, would require employers in the state to reimburse injured workers who use medical cannabis as part of their treatment.
Via Investor Brand Network · August 8, 2025
RockBreaks – AI-Driven Energy Demands Highlight Strategic Value of Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project
As the rise of AI-generated services places extreme pressure on the global power grid, Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is positioned for opportunity. “With data center electrification and sustainability both climbing corporate and regulatory agendas, platinum is emerging as a strategically essential asset. PLG’s Waterberg Project is among the largest and lowest-cost undeveloped platinum group metal resources in the world,” reads a recent article. “In the long run, AI and data-center growth are expected to pressure not just electricity infrastructure but also critical metal supply chains. Platinum’s dual role — as a core catalyst material in PEM systems and as a resilient industrial metal with unique properties — makes it vital to the emerging energy-intelligence economy. As demand for clean, resilient power scales, PLG’s Waterberg positioning and upstream investments align tightly with global market dynamics.”
Via Investor Brand Network · August 8, 2025
AINewsBreaks – Spotlight on ONAR Holding Corp.’s (ONAR) Strategic Playbook: AI-Optimized Campaigns
ONAR (OTCQB: ONAR) was featured in a recent article that discussed its strategy amid the AI era in marketing. “For years, speed was king in digital marketing. Agencies raced to deploy campaigns, iterate quickly, and exploit trends before they faded. But in 2025, this ‘move fast and break things’ mindset is showing its limits. The rise of AI and the complexity of today’s customer journeys require more than just agility; they demand a strategic foundation that connects data, technology, and creativity in a measurable way,” the publication reads. “That shift is giving rise to a new class of agencies focused less on speed for speed’s sake and more on cohesive systems that deliver reliable results. One such firm leading this evolution is ONAR Holding Corp… Cortex is ONAR’s proprietary internal analytics platform, built to forecast optimal advertising spend across channels by using multi-touch attribution data and blending multiple machine learning/AI algorithms. By predicting where ad dollars are likely to generate the highest return, Cortex helps ONAR’s agencies make more informed, data-backed budget decisions for clients. It’s designed to enhance media efficiency by providing clear, actionable insights on spending allocation.”
Via Investor Brand Network · August 8, 2025
TechMediaBreaks – Why AI Maverick Intel Inc. (BINP) Is ‘One to Watch’
AI Maverick Intel (OTCID: BINP) recently rebranded and adopted a new strategic direction focused on AI-powered customer acquisition and automated sales engagement. The company was featured in a recent article that describes its vision “to eliminate friction from the customer acquisition process by replacing traditional, resource-heavy outreach with intelligent, automated engagement. Its mission is to empower organizations to connect with their ideal audiences at high velocity, using real-time insights and personalized communication powered by machine learning. AI Maverick Intel is committed to creating long-term value through innovation, efficiency, and strategic partnerships that enhance operational performance and accelerate growth.”
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – Mega Fortune Company Limited (NASDAQ: MGRT) Closes $15 Million Initial Public Offering
Mega Fortune Company (NASDAQ: MGRT), an Internet of Things (“IoT”) solution provider in Hong Kong, closed its initial public offering of 3,750,000 ordinary shares at $4.00 per share, raising $15 million in gross proceeds before underwriting discounts and expenses. The shares began trading on the Nasdaq Capital Market on July 16, 2025. The company granted the underwriter a 45-day option to purchase up to an additional 562,500 ordinary shares at the public offering price. D. Boral Capital LLC acted as sole bookrunner for the offering.
Via Investor Brand Network · August 8, 2025
Brera Holdings PLC’s (NASDAQ: BREA) Becomes Second Multi-Club Owner in Italy’s Serie B, Signaling Rising Investment Opportunity
Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership (“MCO”) strategy, has become only the second multi-club owner in Italy’s Serie B League, joining City Football Group, the Abu Dhabi United Group-backed conglomerate that owns Manchester City and Palermo FC. The development highlights Brera’s evolving role in the European football market and introduces a new potential avenue for investor exposure to club-level growth ( https://ibn.fm/51sWE ).
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Updates Time for August 12 Q2 2025 Corporate Update Call to 5:00 p.m. ET
SKYX Platforms (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), an advanced and smart home platform technology company with more than 100 issued and pending patents and a portfolio of over 60 lighting and home décor websites, has updated the start time for its previously announced corporate update conference call to present second quarter 2025 results. The call will now be held Tuesday, Aug. 12, 2025, at 5:00 p.m. ET.
Via Investor Brand Network · August 8, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition
NRx Pharmaceuticals (NASDAQ: NRXP), through its wholly owned subsidiary HOPE Therapeutics(TM), Inc., announced it has received final clearance from the Florida Agency for Health Care Administration to proceed with closing its acquisition of revenue-generating, EBITDA-positive Dura Medical LLC, pending customary conditions. Founded in 2018, Dura operates clinics on Florida’s west coast specializing in mental health and chronic pain treatment, offering Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), Spravato(R), Stellate Ganglion Blocks, and Traumatic Incident Reduction Therapy. The company also serves veterans through the Veterans Affairs Community Cares Network. HOPE leaders said the acquisition will expand its Florida network and integrate Dura’s expertise in combining psychedelic medications with neuroplastic technologies for treating suicidal depression and PTSD.
Via Investor Brand Network · August 8, 2025
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Secures Financing Advisors, Expands Offerings to Fund Beacon Gold Mill Restart
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian near-term gold producer, is moving forward with its plans to restart gold production at its wholly owned Beacon Gold Mill by securing corporate finance advisors and expanding its capital-raising efforts ( https://ibn.fm/O5qUa ).
Via Investor Brand Network · August 8, 2025
Gold Makes Modest Gains as Rate Cut Expectations Strengthen
The start of the week saw the price of gold surge after economic data released last week boosted expectations of the Federal Reserve reducing rates of interest. U.S. gold futures saw their price hit $3426.40 per ounce, representing a 0.8% increase. Spot gold also saw its price surge to $3372.15 an ounce, a 0.3% increase.
Via Investor Brand Network · August 8, 2025
China Tells EV Makers to Stop Counterproductive Price Wars
Beijing has warned Chinese electric vehicle makers against taking part in counterproductive price wars to protect the country’s economy. As the largest electric vehicle market, China is home to dozens of EV startups and companies engaged in ferocious competition as they each try to secure a portion of the massive Chinese market for themselves.
Via Investor Brand Network · August 8, 2025
Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells
Researchers in China have discovered a way to supercharge the treatment of lung cancer by transplanting mitochondria into the tumor environment. This transplantation increases the effectiveness of chemotherapy while boosting the immune system’s ability to fight the cancer. The team combined cisplatin (a lung cancer chemo drug) with mitochondrial transplantation.
Via Investor Brand Network · August 8, 2025
Report Says Thousands Have Lost Jobs to AI
Artificial intelligence (AI) is growing into a serious challenge for workers in the U.S. employment landscape. According to a recent report from Challenger, Gray & Christmas, the growing use of generative AI by private companies has triggered over 10,000 redundancies since the start of the year.
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – Standard Lithium Ltd. (NYSE American: SLI) Reports Q2 2025 Progress on SWA Project and Highest Lithium Brine Grade to Date
Standard Lithium (NYSE American: SLI), reported financial and operating results for the three months ended June 30, 2025, highlighting key advancements in its Smackover, Arkansas (“SWA”) Project with joint venture partner Equinor. The company completed all fieldwork for Phase 1, targeting 22,500 tonnes per year of battery-quality lithium carbonate, and recorded its highest lithium concentration to date at 616 mg/L from the Lester well, averaging 582 mg/L. The Arkansas Oil and Gas Commission approved a 2.5% royalty rate for Phase 1—the first lithium-from-brine royalty rate in the state—and unanimously approved the Reynolds Brine Unit. The SWA Project was also designated a critical mineral production initiative under Executive Order 14241. Additional milestones included development of a patented process with Telescope Innovations Corp. to convert lithium hydroxide into battery-quality lithium sulfide for solid-state batteries, and the appointment of two new vice presidents to strengthen strategic and operational capabilities. As of June 30, 2025, the company reported $33.8 million in cash, $30.6 million in working capital, and no debt.
Via Investor Brand Network · August 8, 2025
ONAR Holding Corp. (ONAR) Expands AI Capabilities Through IQSTEL Partnership to Launch Multiagentic Infrastructure
ONAR Holding Corp. (OTCQB: ONAR), a marketing technology company focused on AI-powered growth solutions, has announced the expansion of its strategic partnership with IQSTEL Inc. (NASDAQ: IQST) and IQSTEL’s artificial intelligence subsidiary, Reality Border ( ibn.fm/whT2b ). The collaboration will lead to the development and phased rollout of a multiagentic operating infrastructure designed to support ONAR’s internal teams and client services with a secure, scalable and highly automated system powered by AI.
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) PET Tracer Shows Potential for Monitoring Myelin Integrity in Multiple Sclerosis
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that a Positron Emission Tomography (“PET”) tracer used in collaboration with Massachusetts General Hospital (“MGH”) demonstrated the ability to detect differences across lesions in multiple sclerosis (“MS”) patients that are not visible on conventional MRI. Published Aug. 5, 2025, in the European Journal of Nuclear Medicine and Molecular Imaging, the NIH-funded study found the tracer, [18F]3F4AP—developed by MGH’s Dr. Pedro Brugarolas—shows strong potential as a biomarker for monitoring myelin integrity, demyelination, and treatment response. Quantum BioPharma aims to apply this imaging technology to evaluate its investigational neuroprotective drug, Lucid-21-302 (Lucid-MS), designed to protect the myelin sheath in MS.
Via Investor Brand Network · August 8, 2025
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the U.S. Food and Drug Administration has granted a Type C Meeting on Sept. 18, 2025, to review Chemistry, Manufacturing, and Controls plans for its lead product, AVERSA(TM) Fentanyl. Developed in partnership with Kindeva, the patch integrates Nutriband’s abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch to help prevent abuse, diversion, misuse, and accidental exposure while maintaining access for patients in need. Positioned to be the world’s first abuse-deterrent opioid patch, AVERSA Fentanyl targets peak annual U.S. sales potential of $80 million to $200 million, with future global market expansion planned. The technology is protected by patents in 46 countries.
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – Robot Consulting Co., Ltd. (NASDAQ: LAWR) Closes $15 Million Initial Public Offering
Robot Consulting (NASDAQ: LAWR), a Japanese platform service provider specializing in human resource solutions with planned expansion into legal technology and the metaverse, has closed its initial public offering of 3,750,000 American Depositary Shares (ADSs) at $4 per ADS, raising $15 million in gross proceeds before underwriting discounts and expenses. Each ADS represents one ordinary share. The ADSs began trading on the Nasdaq Capital Market on July 17, 2025. The company has granted underwriters a 45-day option to purchase up to an additional 562,500 ADSs. Net proceeds will fund talent recruitment, product research and development, office and equipment expansion, and general corporate purposes. D. Boral Capital LLC acted as representative of the underwriters with Craft Capital Management LLC as co-underwriter.
Via Investor Brand Network · August 8, 2025
TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Sports.com Studios With GOATS Entertainment in Revenue-Driven Content Partnership
SEGG Media (NASDAQ: SEGG, LTRYW), through its original content division Sports.com Studios Ltd, has entered a co-production alliance with GOATS Entertainment, the premium storytelling brand co-founded by filmmaker Kevin Kaufman and entertainment executive Joe DiMuro. The partnership will transform the legacies of elite athletes into monetizable assets through docuseries, exclusive merchandise, global fan activations, and immersive storytelling, driving high-margin revenue streams across OTT, e-commerce, experiential, and licensing channels. GOATS brings an archive of over 90,000 iconic sports photographs by Walter Iooss Jr. and exclusive filmed interviews with more than 25 legendary athletes, including Kobe Bryant, Tiger Woods, Joe Montana, and Chris Evert. Initial projects include Footballers Live , a behind-the-scenes look at professional footballers, and SAS Unscripted with Ant Middleton , a military competition series filmed in the UAE. Revenue initiatives will span premium content, exclusive streaming rights, limited-edition collectibles, branded partnerships, and live events in key global markets.
Via Investor Brand Network · August 8, 2025
InvestorNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Posts 92% Year-Over-Year Revenue Growth in Q2 2025 on Strong SOBRsure(TM) GEN 2 Sales
SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol monitoring and detection technology, reported a 92.3% year-over-year and 20.3% sequential increase in Q2 2025 revenue to $104,200, driven primarily by SOBRsure(TM) GEN 2 hardware and software sales, which comprised 76.5% of total revenue. Gross margin rose 380 basis points to 57.5%, while net loss narrowed to $2.0 million from $2.1 million in Q2 2024. The company shipped 178 SOBRsure(TM) GEN 2 devices, up 35.9% from Q1, and grew annual recurring software subscription revenue 109.6% year-over-year to 55.2% of quarterly revenue. Operational highlights included independent third-party validation of SOBRsure(TM) GEN 2 performance, launch of an upgraded B2B e-commerce platform, issuance of a European Patent for SOBRcheck(TM), sales team expansion, and entry into the Family Law market. Cash and equivalents stood at $8.5 million as of June 30, 2025.
Via Investor Brand Network · August 8, 2025
AINewsBreaks – Robot Consulting Co., Ltd. (NASDAQ: LAWR) Closes $15 Million Initial Public Offering
Robot Consulting (NASDAQ: LAWR), a Japanese platform service provider specializing in human resource solutions with planned expansion into legal technology and the metaverse, has closed its initial public offering of 3,750,000 American Depositary Shares (ADSs) at $4 per ADS, raising $15 million in gross proceeds before underwriting discounts and expenses. Each ADS represents one ordinary share. The ADSs began trading on the Nasdaq Capital Market on July 17, 2025. The company has granted underwriters a 45-day option to purchase up to an additional 562,500 ADSs. Net proceeds will fund talent recruitment, product research and development, office and equipment expansion, and general corporate purposes. D. Boral Capital LLC acted as representative of the underwriters with Craft Capital Management LLC as co-underwriter.
Via Investor Brand Network · August 8, 2025
MiningNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports Q1 Fiscal 2026 Net Income of $18.1 Million on $81.3 Million Revenue
Silvercorp Metals (TSX: SVM) (NYSE American: SVM) posted Q1 Fiscal 2026 revenue of $81.3 million from sales of 1.8 million ounces (oz) of silver, 1,951 oz of gold, 15.2 million pounds (lb) of lead, and 5.2 million lb of zinc. The company produced 1.8 million oz of silver, 2,050 oz of gold, 15.7 million lb of lead, and 5.2 million lb of zinc, totaling 2.0 million oz silver equivalent, with an all-in sustaining cost of $13.49 per oz of silver, net of by-product credits. Net income attributable to equity shareholders was $18.1 million, or $0.08 per share, with adjusted net income of $21.0 million, or $0.10 per share. EBITDA attributable to equity shareholders was $33.8 million, or $0.15 per share. Operating cash flow reached $48.3 million, generating $22.5 million in free cash flow. During the quarter, Silvercorp invested $18.8 million in China operations, $5.4 million in Ecuador operations, and paid $2.7 million in dividends. The company ended the period with $377.1 million in cash and equivalents, $72.2 million in equity investments, and a $175 million stream financing commitment from Wheaton Precious Metals International Ltd. for the El Domo project.
Via Investor Brand Network · August 8, 2025
States Rush to Complete Clean Energy Projects as Tax Credit Expiry Looms
Dozens of U.S. states are rushing to complete renewable energy projects that are currently under construction before green energy tax credits expire under the recently passed Big Beautiful Bill . With the expiry date for green tax credits fast approaching, state officials are calling for fast‑tracked permitting processes to ensure new renewable energy projects can be connected to the electrical grid before the credits lapse.
Via Investor Brand Network · August 8, 2025
CFTC to Authorize Crypto Spot Trading on Licensed Exchanges
The U.S. Commodity Futures Trading Commission (CFTC) has announced plans to launch a new program allowing trading of crypto spot contracts on a regulated futures exchange under its authority.
Via Investor Brand Network · August 8, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable
The medical community stands at the threshold of what could become the most significant advancement in cancer detection since the introduction of mammography over half a century ago. While survival rates for many cancers have improved dramatically through better treatments, the fundamental challenge of early detection remains largely unchanged. Current screening technologies, despite decades of refinement, still miss cancers in their earliest, most treatable stages, while simultaneously generating false positives that lead to unnecessary anxiety and interventions.
Via Investor Brand Network · August 8, 2025
Smaller Firms are Increasingly Adding Ether to Their Reserves
More and more small public companies are now putting their money into Ether, the second-largest cryptocurrency after Bitcoin. As of the end of July 2025, these companies held nearly $3.5 billion worth of Ether, according to data from recent filings. That’s a major jump from just under $400 million at the end of 2024.
Via Investor Brand Network · August 8, 2025
AINewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Posts 42% YoY Revenue and Gross Profit Growth and Record Cash Position
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, reported Q2 2025 revenue of $3.1 million, up 42% year-over-year, Q2 2025 gross profit of $2.0 million, up 42% year-over-year and ended the quarter with a record $819 million in cash following a successful $400 million At-the-market (ATM) equity offering.
Via Investor Brand Network · August 8, 2025
AINewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Featured in NetworkNewsAudio APR on AI Wearables Market Surge
Wearable Devices (NASDAQ: WLDS, WLDSW), a pioneer in AI-powered neural input technology, is spotlighted in the NetworkNewsAudio APR titled “Neural Tech Drives the Growth of the AI Wearables Market.” The editorial explores how WLDS is helping shape the $260 billion projected wearables market through innovations like its Mudra Link wristband and LMM platform, which enable intuitive, touchless control of digital devices. The company’s expansion into Japan, new U.S. patents and enterprise-focused rollout strategy position it as a key player in neural-interactive tech for consumer, industrial and healthcare use.
Via Investor Brand Network · August 8, 2025
420 with CNW — Marijuana Firms Partner with Media Outlets to Boost Visibility
Two marijuana brands based in Colorado have come together to launch a limited-edition series of infused pre-rolls in partnership with a long-standing independent media house. The collaboration involves Meraki Brands (a cannabis cultivator), the solventless concentrate producer Mighty Melts, and Denver’s alternative weekly newspaper, Westword.
Via Investor Brand Network · August 7, 2025
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Featured in NNW Editorial on Rare Disease Innovation
Soligenix (NASDAQ: SNGX) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators.” The article underscores the growing healthcare challenges of rare diseases among aging Americans and the urgent need for effective therapies. Soligenix is spotlighted for its HyBryte(TM) platform, a novel treatment for cutaneous T-cell lymphoma (CTCL), a rare skin cancer primarily affecting older adults. With U.S.-based manufacturing now established for HyBryte’s active ingredient, Soligenix demonstrates a commitment to domestic innovation and support for underserved patient populations.
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – Massimo Group (NASDAQ: MAMO) Expands Golf Cart Production to Vietnam to Boost Supply Chain and Meet Demand
Massimo Group (NASDAQ: MAMO) announced it will begin receiving deliveries of its new six-seater golf carts from a manufacturing partner in Vietnam, complementing production at its Garland, Texas facility. The Vietnam expansion supports supply chain diversification, improved lead times, and cost efficiencies. The feature-rich MVR4X model offers a 60km range, 48V motor, and advanced safety features, positioning Massimo to meet growing U.S. demand while protecting long-term margins.
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) to Host Q2 2025 Corporate Update Call on August 12
SKYX Platforms (NASDAQ: SKYX), doing business as SKYX Technologies, announced it will host a Corporate Update conference call to review its second quarter 2025 financial results on Tuesday, August 12, 2025, at 10:00 a.m. ET. The advanced smart home technology company, which holds more than 100 global patents and operates over 60 lighting and home décor websites, will be represented by Founder and Executive Chairman Rani Kohen, President Steve Schmidt, and Co-CEO Lenny Sokolow.
Via Investor Brand Network · August 7, 2025
TinyGemsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Launches Open-Source Toolkit for Quantum AI and Machine Learning
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has released a new suite of developer tools aimed at accelerating quantum artificial intelligence (AI) and machine learning (ML) innovation. The launch includes an open-source quantum AI developer toolkit and a demo that allows developers to integrate D-Wave’s quantum processors into modern AI and ML frameworks.
Via Investor Brand Network · August 7, 2025
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Launches Diamond Drilling at Swanson Project, Beacon Gold Mill Valuation Is Finalized
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0), a Canadian near-term gold producer, has initiated diamond drilling at its Swanson Gold Project in the prolific Abitibi region of Quebec, following receipt of key permits. The program, covering at least 5,000 metres of drilling, is focused on priority targets within the Swanson Gold Deposit and other promising zones, including Bartec, Jolin, and Marimac. According to the company, these zones were identified through detailed geological and geophysical work, including magnetic surveys, induced polarization (“IP”), and soil geochemistry analysis ( https://ibn.fm/KGilj ).
Via Investor Brand Network · August 7, 2025
AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Showcased in NNW Editorial on AI-Driven Hospitality Revolution
Nightfood Holdings (OTCQB: NGTF), an AI-powered hospitality innovator, announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “AI, Robotics Are Reshaping the Future of Hospitality.” The piece highlights how automation is cutting hotel operational costs by up to 40% while boosting guest satisfaction. NGTF is spotlighted for its Robotics-as-a-Service (RaaS) model and upcoming acquisition of a 155-room Holiday Inn in Victorville, California, which will serve as its first automated hotel featuring guest-facing robots developed by subsidiary Skytech Automated Solutions. In partnership with Bear Robotics, Nightfood plans to implement these technologies across a projected $80 million hotel portfolio.
Via Investor Brand Network · August 7, 2025
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Secures Full Patent Coverage for New Crystalline Form of Buntanetap
Annovis Bio (NYSE: ANVS), a late-stage clinical company advancing treatments for neurodegenerative diseases, announced the successful transfer and expansion of its intellectual property to fully cover both the original and new crystalline forms of buntanetap. The comprehensive patent portfolio, now protected through 2046, includes composition of matter, mechanism of action, and use in multiple indications. The new form offers improved stability with bioequivalence confirmed in animal and human studies, as presented at the 2025 Alzheimer’s Association International Conference.
Via Investor Brand Network · August 7, 2025
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Receives EU Approval to Launch EMBRACE Phase 3 MDD Study
Cybin (NYSE American: CYBN) (Cboe CA: CYBN), a clinical-stage neuropsychiatry company, announced European approval to initiate its EMBRACE(TM) Phase 3 study in Ireland, Poland, and Greece. EMBRACE is part of the Company’s PARADIGM(R) program evaluating CYB003, a proprietary deuterated psilocin analog granted Breakthrough Therapy Designation by the FDA for Major Depressive Disorder. The study will enroll 330 participants with inadequately controlled MDD symptoms across multiple international sites, assessing two CYB003 dose levels against placebo.
Via Investor Brand Network · August 7, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging
Accurate detection and diagnosis remain critical challenges in the fight against breast cancer, especially for women with dense breast tissue where mammography falls short. Izotropic (CSE: IZO) (OTCQB: IZOZF) is at the forefront of addressing these gaps through its IzoView Breast CT Imaging System, a contrast-enhanced CT platform designed for enhanced screening precision. The company is actively preparing for the commercialization of IzoView, signaling a pivotal development in breast cancer imaging.
Via Investor Brand Network · August 7, 2025
AINewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Expands Global Patent Protection for AI-Based Explosives Detection
Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense solutions, announced the international publication of its patent applications in Australia, Israel, and Europe for its SpotlightAI(TM) explosives detection technology. The Company’s SPOTD system, capable of identifying over 150 explosive threats in drone imagery, is now protected under the Patent Cooperation Treaty in 47 jurisdictions. Backed by a granted U.S. patent valid through 2043, Safe Pro’s proprietary tech supports real-time and cloud-based detection and has identified over 31,600 threats across 7,819 hectares in Ukraine.
Via Investor Brand Network · August 7, 2025
DefenseNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Expands Global Patent Protection for AI-Based Explosives Detection
Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense solutions, announced the international publication of its patent applications in Australia, Israel, and Europe for its SpotlightAI(TM) explosives detection technology. The Company’s SPOTD system, capable of identifying over 150 explosive threats in drone imagery, is now protected under the Patent Cooperation Treaty in 47 jurisdictions. Backed by a granted U.S. patent valid through 2043, Safe Pro’s proprietary tech supports real-time and cloud-based detection and has identified over 31,600 threats across 7,819 hectares in Ukraine.
Via Investor Brand Network · August 7, 2025
MiningNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Reports New Copper Intercepts and Progress at Storm Project
Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) reported new near-surface copper intercepts from recent RC drilling at the Storm Copper Project on Somerset Island, Nunavut, under joint venture with American West Metals. Several intersections lie outside the current conceptual pit walls, indicating potential to expand the mineral resource. Drilling also reached the Deep Cirrus target, intersecting copper sulphide mineralization and favorable stratigraphy. Final results from the MobileMT geophysical survey are expected soon to guide further exploration at depth.
Via Investor Brand Network · August 7, 2025
BP Announces a Major Oil Discovery in Brazil
Earlier this week, British Petroleum (BP) announced that it had made a resource discovery that eclipsed any they have made in over two decades. These last few years have seen the multinational oil and gas firm shift its focus back to fossil fuels after failing to reduce hydrocarbon production, where it focused on energy alternatives that were low in carbon. Prior to this, the firm was planning to become a net zero company.
Via Investor Brand Network · August 7, 2025
VinFast Opens EV Plant in India After Halting its US Expansion
Vietnamese electric vehicle company VinFast has launched an electric vehicle manufacturing facility in India, the second-largest economy in Asia, several months after it paused its plans to expand to the U.S., Canada, and Europe.
Via Investor Brand Network · August 7, 2025
Water Scarcity Threatens AI Growth in the Gulf
The Gulf region is locked in a multitrillion-dollar pursuit to build global leadership in AI. Yet this ambition faces a formidable obstacle— access to water . Data centers supporting AI in Saudi Arabia, the UAE, and neighboring countries are guzzling massive volumes of water.
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Reports Early Drilling Progress at Swanson Gold Project in Québec
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the completion of seven diamond drill holes totaling 1,764 meters at its Swanson Gold Project in Québec’s Abitibi Greenstone Belt. Core logging revealed pathfinder minerals, widespread alteration, and a standout 17.9-meter sulphide-rich zone in hole SW-025-038. Samples from three holes have been sent for assay, with results pending. The fully funded 5,000-meter drill program aims to expand known mineralization and test additional regional targets.
Via Investor Brand Network · August 7, 2025
BioMedNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Multilingual Podcast to Raise Awareness of Breast Imaging Innovation
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging technologies for breast cancer detection, has launched a multilingual podcast series titled Beyond the Mammogram: Rethinking the Future of Breast Imaging . Available in seven languages, the series aims to inform global audiences about limitations in current imaging tools and the need for more accurate technologies like Izotropic’s IzoView Breast CT system. The podcast repurposes public data into educational content for patients, professionals, and stakeholders as the Company moves toward regulatory approval.
Via Investor Brand Network · August 7, 2025
D-Wave Quantum Inc. (NYSE: QBTS): 27% of Surveyed Business Leaders Expect $5M+ ROI from Quantum Optimization Within First Year
A new survey released by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, suggests that quantum computing is gaining traction as a business tool, particularly for optimization problems. The findings point to a growing belief among surveyed decision-makers that classical computing may no longer be sufficient for the operational challenges they face ( https://ibn.fm/YPAsc ).
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Announces $2.4 Million Warrant Inducement Transaction
Wearable Devices (NASDAQ: WLDS, WLDSW), an award-winning AI-based gesture control technology company, has entered a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 1,661,000 ordinary shares at $1.45 per share, generating approximately $2.4 million in gross proceeds. In exchange, the investor will receive 3,322,000 new unregistered warrants in a private placement, exercisable at $1.71 per share upon shareholder approval. Net proceeds will be used for working capital and general corporate purposes. The closing is expected on or about August 7, 2025, subject to customary conditions.
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – McEwen Inc. (NYSE: MUX) (TSX: MUX) Posts Q2 Profit, Reaffirms 2025 Outlook and Highlights Key Growth Catalysts
McEwen (NYSE: MUX) (TSX: MUX) reported Q2 2025 net income of $3 million, or $0.06 per share, compared to a $13 million loss in Q2 2024, supported by stronger gold prices and improved margins. Adjusted EBITDA rose to $17.3 million on $46.7 million in revenue from 14,549 gold equivalent ounces (GEOs) sold. While production fell year-over-year, the Company maintained its full-year guidance of 120,000–140,000 GEOs and anticipates lower unit costs in H2. McEwen also noted progress on development projects, including its 46.4% stake in McEwen Copper and the Los Azules Feasibility Study, expected in late Q3 2025, as well as seven near-term catalysts through 2026.
Via Investor Brand Network · August 7, 2025
MiningNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reports Q2 2025 Results, Highlights Record Uranium Grades and REE Progress
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium and rare earth elements, reported financial results for Q2 2025 and emphasized exceptional production at its Pinyon Plain uranium mine, calling it possibly the highest-grade U.S. uranium site in history. While limited uranium sales led to a segment loss, strong contract deliveries and potential spot market sales are expected to generate substantial cash flow starting this year. The Company also advanced its rare earth operations, including pilot-scale dysprosium production in Utah and final regulatory approval for the Donald Project in Australia, as global REE prices rise sharply.
Via Investor Brand Network · August 7, 2025
Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has completed targeted patient enrollment in Japan for its ongoing Phase 2 HARMONIC(TM) clinical trial evaluating investigational drug candidate LP-300 in never-smoker non-small cell lung cancer (“NSCLC”) patients ( https://ibn.fm/JXFqG ).
Via Investor Brand Network · August 7, 2025
Researchers in Ireland Test Kites Designed to Generate Wind Energy
Researchers in Ireland are testing the feasibility of using giant kites to generate green electricity. Located in Bangor Erris in Mayo County in western Ireland, the designated airborne wind energy (AWE) test hub serves as the main testing ground for this novel source of renewable energy.
Via Investor Brand Network · August 7, 2025
FinCEN Warns the US Public of Increases in Crypto Scams at ATMs
The US Financial Crimes Enforcement Network (FinCEN) has cautioned that fraudsters are increasingly targeting victims through scams involving cryptocurrency ATMs .
Via Investor Brand Network · August 7, 2025
Utility Firms Eye Retired EV Batteries for Energy Storage
As the world moves towards cleaner energy, retired electric vehicle (EV) batteries are finding a new purpose. Utility companies and energy firms are now looking at these used batteries as a low-cost solution for large-scale energy storage. One company leading this change is B2U Storage Solutions, based in California.
Via Investor Brand Network · August 7, 2025
InvestorNewsBreaks – SOBRsafe Inc. (NASDAQ: SOBR) Secures European Patent for SOBRcheck Alcohol Detection Device
SOBRsafe (NASDAQ: SOBR), a leader in next-generation alcohol monitoring technology, announced the European Patent Office has granted European Patent No. EP4171362 for its SOBRcheck(TM) device. The patent covers the Company’s proprietary noninvasive transdermal alcohol screening system, which uses skin-contact verification, biometric ID scanning, and wireless data transmission to detect alcohol consumption without intrusive sampling. The intellectual property strengthens SOBRsafe’s position in workplace safety, judicial compliance, and wellness markets ahead of planned European pilot programs in the second half of 2025.
Via Investor Brand Network · August 7, 2025
420 with CNW — Massachusetts Marijuana Regulators to Receive Public Comment on Social Consumption Site Regulations.
3Massachusetts marijuana regulators are seeking input from the public after approving a draft set of rules that could pave the way for cannabis use in public spaces and events.
Via Investor Brand Network · August 6, 2025
MissionIRNewsBreaks – Alliance Entertainment (NASDAQ: AENT) Elevates Seven Key Leaders to Senior VP Roles
Alliance Entertainment Holding Corp. (NASDAQ: AENT) has promoted seven seasoned executives to Senior Vice President roles across its sales, fulfillment, IT, finance, and legal departments. The move reflects the company’s focus on accelerating growth in licensed collectibles and physical media through operational efficiency, exclusive content expansion, and a scalable, capital-light fulfillment model. CEO Jeff Walker praised the newly appointed SVPs for driving innovation across core functions, including data infrastructure, automation, and financial strategy. Chairman Bruce Ogilvie added that their elevation reflects the company’s confidence in their continued contributions as Alliance advances its position in the global collectibles ecosystem. Shares of Alliance Entertainment were trading up 5.81% at $5.28 on Wednesday morning.
Via Investor Brand Network · August 6, 2025
Red Cat Holdings Inc. (NASDAQ: RCAT) Endorses White House Push for Drone Industry Reform and National Security
Red Cat Holdings Inc. (NASDAQ: RCAT) has announced its support for recent executive orders from the White House aimed at strengthening the domestic drone industry and enhancing national security. The new measures are designed to eliminate regulatory bottlenecks, fast-track federal drone approvals, and expand deployment across both federal and commercial domains.
Via Investor Brand Network · August 6, 2025
Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has unveiled a new artificial intelligence module designed to predict the effectiveness of cancer treatment combinations involving DNA-damaging agents (“DDAs”) and DNA damage response inhibitors (“DDRis”). The technology is integrated into the company’s RADR(R) platform, which supports AI-guided drug development.
Via Investor Brand Network · August 6, 2025